Chonluten 20 mg

Subtotal	$0.00
Shipping	$0.00
Total	$0.00

Chonluten 20 mg - Peptide Sciences USA Research Peptides

Active Substance: Chonluten
Concentration: 20 mg per vial
Pack Size: Single vial (lyophilized powder)
Manufacturer: Peptide Sciences USA
Brand Name: Chonluten
Molecular Formula: C₁₁H₁₇N₃O₈
Molecular Weight: 319.27 g/mol
Sequence: Glu-Asp-Gly
Synonyms: Tripeptide T-34, EDG, AC-7

Manufacturer	Peptide Sciences USA
Brand	Chonluten
Substance	Chonluten
Concentration	20 mg
Pack Size	vial

Out of Stock

Research Peptides Description

Chonluten 20 mg – The Vanguard of Respiratory Vitality

Product Summary

Envision a research frontier where lung tissues thrive, inflammation subsides, and age-related decline slows. Chonluten 20 mg vial from Peptide Sciences USA, a tripeptide bioregulator, delivers this potential. By targeting bronchial mucosa and modulating gene expression, Chonluten enhances lung repair, reduces inflammation, and supports geroprotection, offering a cutting-edge tool for pioneering respiratory and longevity research.

How Chonluten Works

Chonluten, a tripeptide with the sequence Glu-Asp-Gly, is a bioregulator that interacts with DNA to modulate gene expression, particularly in lung and gastrointestinal tissues. It upregulates genes like c-Fos, HSP70, SOD, and COX-2, while suppressing proinflammatory cytokines (e.g., TNF-α, IL-6, IL-17) via STAT1/STAT3 pathways. This reduces inflammation by 40–50% in bronchial mucosa and enhances surfactant production, stabilizing lung function in models of COPD and asthma.

In preclinical studies, Chonluten normalized bronchial mucosal function in rats exposed to NO2, eliminating goblet cell hyperplasia and lymphocytic infiltration. It also increased aerobic capacity and oxygen pulse in athletes, suggesting enhanced respiratory reserve. Its geroprotective effects stem from stabilizing DNA methylation, potentially extending cell lifespan and reducing spontaneous tumor development by up to 40% in animal models, making it a versatile candidate for lung health and anti-aging research.

Why Choose Chonluten 20 mg?

Chonluten is a trailblazer in respiratory and longevity research, offering transformative benefits. Here's why it stands out:

Lung Tissue Repair: Restores bronchial mucosa and enhances surfactant production, improving lung function by 40–50% in COPD and asthma models.
Anti-Inflammatory Power: Reduces TNF-α, IL-6, and IL-17 levels, mitigating inflammation in lung and GI tissues.
Geroprotection: Stabilizes DNA methylation, slowing cellular senescence and reducing tumor development by up to 40%.
Athletic Performance: Increases aerobic capacity and oxygen pulse, supporting respiratory reserve in high-performance research models.
Superior Quality: Peptide Sciences USA ensures 99% purity through advanced synthesis, delivering reliable research results.

Chonluten 20 mg empowers researchers to breathe new life into lung health and longevity studies, backed by cutting-edge bioregulator peptide science.

Product Specifications

Peptide Sciences USA's Chonluten 20 mg vial is crafted for precision in respiratory research, delivering exceptional quality. Here's the breakdown:

Composition: Contains 20 mg of Chonluten (C₁₁H₁₇N₃O₈, molecular weight 319.27 g/mol).
Pack Size: Single vial of lyophilized powder, requiring reconstitution for subcutaneous or intramuscular injection.
Manufacturing: Produced by Peptide Sciences USA with 99% purity, verified by High-Performance Liquid Chromatography and Mass Spectrometry.
Usage Guidelines: Reconstitute with bacteriostatic water and administer via subcutaneous or intramuscular injection, typically at 0.1–0.2 mg/day for 10–30 days in research protocols. Use under professional supervision.
Storage: Store lyophilized powder at -20°C. After reconstitution, refrigerate at 2–8°C and use within 30 days.
Safety: Preclinical studies report no significant side effects; limited human data requires research oversight.

This peptide is for research purposes only, providing a robust platform for studying lung health and longevity.

Legal Disclaimer

Chonluten 20 mg is supplied for research purposes only and is not FDA-approved for human use. It is not intended to diagnose, treat, cure, or prevent any condition. Consult a licensed professional before use. Peptide Sciences USA assumes no liability for misuse. All information is educational and based on preclinical research.

Frequently Asked Questions

What are Chonluten peptide benefits?

Chonluten supports lung tissue repair, reduces inflammation by 40–50%, enhances aerobic capacity, and promotes geroprotection by stabilizing DNA methylation, making it ideal for researching COPD, asthma, and longevity.,

What does Chonluten peptide do?

Chonluten modulates gene expression (e.g., c-Fos, HSP70, SOD) to normalize bronchial mucosal function, reduce inflammation, and enhance cell survival in lung and GI tissues, supporting research into respiratory health and anti-aging.

What are possible Chonluten peptide side effects?

Preclinical studies report no significant side effects, with rare instances of mild digestive upset. Limited human data necessitates professional oversight for research safety.

How is Chonluten 20 mg administered in research?

Chonluten is supplied as a 20 mg lyophilized powder. Reconstitute with bacteriostatic water and administer via subcutaneous or intramuscular injection, typically at 0.1–0.2 mg/day for 10–30 days in research protocols, under professional guidance.

How should Chonluten 20 mg be stored?

Store the lyophilized powder at -20°C. After reconstitution with bacteriostatic water, refrigerate at 2–8°C and use within 30 days to maintain potency.